European Procedure Numbers for Gynecological Devices 2016 - MedPro - Research and Markets

Research and Markets has announced the addition of the "European Procedure Numbers for Gynecological Devices 2016 - MedPro" report to their offering.

In the case of Uterine Fibroid Embolization, the number of patients receiving treatments also demonstrates the number of procedures being performed using Microspheres compared to PVA particles. The changes in Essure® procedures provides a context for the adverse health effects currently being publicized and the impact it is having on potential patients. Finally, for both Female Urinary Incontinence Sling procedures and Pelvic Organ Prolapse procedures, there is a 1:1 ratio between unit sales and the number of procedures performed.

However, the procedure numbers illustrate doctor and patient preferences as there is a shift in the types of slings and meshes used for procedures. The procedures included in this segment all link to the unit sales for capital equipment. The Assisted Reproduction device market demonstrates the relationship between the average number and types of supplies used per cycle of IVF or ICSI. The procedural data also helps to clarify the unit sales in the different sub-segments of the gynecology market.

Key Topics Covered:

• Executive Summary
• Competitive Analysis
• Market Trends
• Market Developments
• Procedure Numbers
• Markets Included
• Key Report Updates
• Version History
  

1. Research Methodology

1.1 Research Scope

1.2 9-Step Methodology

2. Country Profiles

2.1 Introduction

3. European Gynecological Device Market Procedure Numbers

3.1 Procedure Analysis And Forecast

Companies Mentioned

• Bayer
• Karl Storz
• Cooper Surgical
• Olympus
• Richard Wolf
• Cook Medical
• Johnson & Johnson
• Astora Women's Health
• Vitrolife
• Boston Scientific
• Johnson & Johnson
• Hologic
  

For more information about this report visit http://www.researchandmarkets.com/research/l9qhqc/european

View source version on businesswire.com: http://www.businesswire.com/news/home/20170421005355/en/